Why Is Boston Scientific (BSX) Reorganizing Into Three Segments Under A New COO?

Boston Scientific (NYSE: BSX) appointed Joseph M. Fitzgerald as executive vice president and chief operating officer, effective January 1, 2027. The company plans to reorganize its global operations into three reportable segments: Interventional Therapies, Rhythm Solutions, and MedSurg. Fitzgerald is expected to oversee the transition to the new segment structure as part of a broader operational realignment. The leadership change and shift to Interventional Therapies, Rhythm Solutions, and...